The Spanish competition authority, known as CNMC, has released a statement regarding the new law governing medicines and health products. This law is designed to align with the authority's earlier recommendations, which were aimed at improving competition within the pharmaceutical sector.

The CNMC emphasizes the importance of effective competition in ensuring that consumers have access to a variety of medicines and health products at fair prices. By following its recommendations, the new legislation seeks to prevent anti-competitive practices that could harm consumers and businesses alike.

In addition to promoting competition, the CNMC is committed to monitoring market activities to detect and prevent any practices that may undermine fair competition. This proactive approach is part of the authority's broader mission to safeguard consumer interests and maintain a balanced market environment.